Relatively simple and 
Introduction
Vaginal candidiasis is a common and chronic ailment in women of child-bearing age. The 
Experimental infection
The vaginal infection of ovariectomized rats with C. albicans SC 5314 was studied macroscopically, microscopically and culturally. Grossly, no signs of infection were evident throughout the course of several long-term experiments. Vaginal discharges or plaques on the vaginal mucosa, commonly found in human candidal vaginitis, were not observed. By microscopic examination 24 hr after infection the vaginal mucosa was found to exhibit the classical signs of oestrus; marked hyperkeratosis and pronounced exfoliation of the stratum corneum. Blastospores of C. albicans were observed in the superficial layers of the vaginal mucosa and lying free in the vaginal cavity. A slight inflammatory response was noted in the subcutaneous tissues. By 72 hr after infection the concentration of blastospores appeared to have diminished but a few mycelial elements were observed in the stratum corneum.
The magnitude and extent of vaginal colonization by C. albicans was followed for several weeks using culture of vaginal washings to quantitate candidal CFU (Fig. 1) (Mizuba et al., 1974; Polak, 1978) determine by means of a parallel line assay the potency of a test drug relative to a reference drug. Scholer (1960) reported that the vaginal candidiasis model in ovariectomized rats responded to chemotherapy with antifungal agents when they were administered systemically or locally. In the present study it was found that the model infection responded to a wide variety of antifungal agents applied locally in cream, ointment or gel formulations. It was also demonstrated that the model infection would respond to chemotherapy with both solid and liquid drug formulations (Mizuba et al., 1974) . Consequently, one aspect of the rat model that enhances its effectiveness is its capacity to respond to chemotherapy with various types of antifungal agents administered by different routes and in diverse dosage forms.
As with most model infections, there are certain differences between the experimental infection and the natural infection. For example, the experimental infection is rather acute and self-limiting when compared to the chronic, persistent ailment found in women; the experimental infection does not exhibit vulval involvement, vaginal discharges, or mural plaques as is often observed in women; the vaginal pH in the experimental infection is less acidic than in the natural infection; and the normal flora and vaginal mucosa are somewhat different in the 2 hosts. On the other hand, the experimental infection somewhat resembles the natural infection in that candidal elements are localized superficially in the vagina, both yeast and mycelial forms of C. albicans are found, and a microenvironment similar to that found in humans (mixed bacterial flora, vaginal secretions, and pH, etc.) is present. The rat model provides some of the same variables encountered clinically; individual variations in vaginal size and shape, ecosystems, responsiveness to chemotherapy, and retention of drugs.
While differences between the experimental and natural infection do exist, the model does meet various criteria for use as a successful screening tool: (i) the infection is easily produced and quantitated, (ii) the infection is responsive to clinically effective drugs, (iii) the infection can demonstrate doseresponse relationships, and indicate relative potency, and (iv) results from chemotherapeutic studies in the model appear to have some predictive value for clinical studies. Thus, using the test procedures described earlier, the vaginal candidiasis model would appear to have a definite role as a screening tool in the preclinical evaluation of potential antifungal agents.
